Surgery Treatment Improved the Overall Survival Rate in Locoregional Myxoid Leiomyosarcoma than Other Myxosarcomas in the United States

Table 3

Univariate and multivariate analyses on locoregional myxoid leiomyosarcoma in the United States.

Demographic chch	Myxoid leiomyosarcoma; Total ()
Disease
	Univariate			Multivariate
	Hazard ratio	95% CI (lower-upper)	value	Hazard ratio	95% CI (lower-upper)	value
Age (years)
<50 vs. >50	1.054	0.655-1.699	0.827	0.619	0.336-1.14	0.124
Sex
Male vs. female	0.887	0.493-1.597	0.690	1.731	0.618-4.848	0.296
Race
White	Ref			Ref
Black	0.764	0.399-1.462	0.416	0.363	0.154-0.855	0.021
Other	0.613	0.149-2.518	0.498	1.555	0.358-6.756	0.556
Grade
Grade I	Ref			Ref
Grade II	1.149	0.449-2.939	0.772	1.406	0.519-3.803	0.503
Grade III	0.901	0.360-2.256	0.824	1.068	0.410-2.786	0.892
Grade IV	1.195	0.468-3.053	0.710	3.748	1.234-11.384	0.02
Unknown	0.933	0.405-2.148	0.870	1.130	0.475-2.686	0.783
Surgery
Yes vs. no	0.881	0.320-2.425	0.806	1.431	0.360-5.681	0.611
Radiotherapy
Yes vs. no	1.593	0.993-2.557	0.053	0.529	0.302-0.926	0.026
Chemotherapy
Yes vs. no	0.971	0.435-2.169	0.943	0.740	0.292-1.873	0.525

chch: characteristics; ref: reference.